BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,039 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,691,086 | -20.3% | 80,451 | +1.8% | 0.01% | -27.8% |
Q1 2024 | $3,376,332 | +5.2% | 78,997 | -4.8% | 0.02% | +5.9% |
Q4 2023 | $3,209,437 | +1.2% | 83,017 | -1.2% | 0.02% | -10.5% |
Q3 2023 | $3,171,066 | -11.3% | 84,024 | +7.1% | 0.02% | -9.5% |
Q2 2023 | $3,575,048 | -43.3% | 78,469 | -49.5% | 0.02% | -47.5% |
Q1 2023 | $6,308,621 | -7.3% | 155,538 | +16.5% | 0.04% | -16.7% |
Q4 2022 | $6,806,738 | -99.9% | 133,544 | -28.1% | 0.05% | -37.7% |
Q3 2022 | $9,999,486,000 | +91.5% | 185,657 | +128.4% | 0.08% | +108.1% |
Q2 2022 | $5,222,027,000 | -13.5% | 81,302 | +4.4% | 0.04% | +2.8% |
Q1 2022 | $6,036,489,000 | -11.2% | 77,850 | -1.7% | 0.04% | -10.0% |
Q4 2021 | $6,796,554,000 | +10.3% | 79,177 | +3.3% | 0.04% | 0.0% |
Q3 2021 | $6,162,868,000 | +3.8% | 76,624 | +3.8% | 0.04% | +2.6% |
Q2 2021 | $5,939,612,000 | +1.3% | 73,784 | +6.1% | 0.04% | -9.3% |
Q1 2021 | $5,862,473,000 | +18.7% | 69,510 | +12.9% | 0.04% | 0.0% |
Q4 2020 | $4,939,013,000 | +3.4% | 61,553 | +3.6% | 0.04% | -15.7% |
Q3 2020 | $4,776,626,000 | -2.4% | 59,396 | +4.5% | 0.05% | -10.5% |
Q2 2020 | $4,894,613,000 | +20.1% | 56,848 | +13.2% | 0.06% | -5.0% |
Q1 2020 | $4,076,388,000 | -18.1% | 50,208 | -15.7% | 0.06% | +22.4% |
Q4 2019 | $4,980,156,000 | +10.1% | 59,557 | +15.2% | 0.05% | -3.9% |
Q3 2019 | $4,522,986,000 | +13.2% | 51,709 | +6.0% | 0.05% | +10.9% |
Q2 2019 | $3,996,474,000 | -9.9% | 48,797 | -10.6% | 0.05% | -9.8% |
Q1 2019 | $4,436,680,000 | +12.7% | 54,565 | -8.8% | 0.05% | 0.0% |
Q4 2018 | $3,936,694,000 | -23.6% | 59,810 | -10.5% | 0.05% | -12.1% |
Q3 2018 | $5,151,077,000 | +6.8% | 66,819 | +2.3% | 0.06% | +1.8% |
Q2 2018 | $4,823,820,000 | +26.9% | 65,328 | +11.8% | 0.06% | +23.9% |
Q1 2018 | $3,800,157,000 | +8.0% | 58,428 | +7.3% | 0.05% | +9.5% |
Q4 2017 | $3,518,226,000 | +4.7% | 54,428 | +1.7% | 0.04% | -6.7% |
Q3 2017 | $3,358,882,000 | +1.9% | 53,528 | -1.7% | 0.04% | -6.2% |
Q2 2017 | $3,295,071,000 | +13.6% | 54,428 | -2.7% | 0.05% | +4.3% |
Q1 2017 | $2,900,426,000 | -46.3% | 55,928 | -54.1% | 0.05% | -53.5% |
Q4 2016 | $5,397,420,000 | +30.6% | 121,728 | +40.2% | 0.10% | +22.2% |
Q3 2016 | $4,133,013,000 | -56.8% | 86,828 | -58.9% | 0.08% | -60.1% |
Q2 2016 | $9,560,774,000 | -6.1% | 211,428 | -14.7% | 0.20% | -4.7% |
Q1 2016 | $10,186,649,000 | +51.7% | 247,971 | +40.8% | 0.21% | +47.9% |
Q4 2015 | $6,717,109,000 | +145.9% | 176,071 | +111.7% | 0.14% | +111.8% |
Q3 2015 | $2,732,167,000 | -50.8% | 83,171 | +4.7% | 0.07% | -44.7% |
Q2 2015 | $5,557,407,000 | -0.2% | 79,471 | -2.2% | 0.12% | -0.8% |
Q1 2015 | $5,567,064,000 | +173.5% | 81,271 | +192.6% | 0.12% | +169.6% |
Q4 2014 | $2,035,337,000 | -32.8% | 27,771 | -34.1% | 0.05% | -31.3% |
Q3 2014 | $3,026,613,000 | +4.2% | 42,171 | +5.0% | 0.07% | +9.8% |
Q2 2014 | $2,904,363,000 | +94.5% | 40,171 | +87.1% | 0.06% | +74.3% |
Q4 2013 | $1,493,308,000 | +73.9% | 21,471 | +64.3% | 0.04% | +45.8% |
Q3 2013 | $858,634,000 | +11.0% | 13,071 | +17.0% | 0.02% | +4.3% |
Q2 2013 | $773,815,000 | – | 11,171 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |